Amyris (AMRS) Tops Q1 EPS by 37c

Amyris (: AMRS) reported Q1 EPS of $0.35, $0.37 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $177 million versus the consensus estimate of $73.36 million.

GUIDANCE:

Amyris sees FY2021 revenue of $400 million, versus the consensus of $337.5 million.

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c